Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma-Reference-Cited by-同舟云学术

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma

Published:2023-08-22 Issue:16 Volume:8 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Kobayashi Shin,Tokita Serina,Moniwa Keigo^ORCID,Kitahara Katsuyuki,Iuchi Hiromichi,Matsuo Kazuhiko,Kakizaki Hidehiro,Kanaseki Takayuki^ORCID,Torigoe Toshihiko^ORCID

Funder

Japan Agency for Medical Research and Development

Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) KAKENHI

MEXT Promotion of Distinctive Joint Research Center Program

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/167712/files/pdf

Reference30 articles.

1. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

2. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

3. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

4. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

5. Signatures of mutational processes in human cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy;Experimental Hematology & Oncology;2024-04-03

3. Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy;Cancer Science;2024-02-21